Trade Assist May Not Be Available For All Jump Trades (See Trade Plan

Ticker delayed 20 minutes



Avg Daily Volume: 11,416,668    Market Cap: 3.14B
Sector: Services    Short Interest: 9.18


     THIS QTR:   EPS:      -.66/share     REV:  1,820/M
     LAST QTR:  EPS:       1.86/share     ACTUAL: 1.88/share  (BEAT)
     NEXT QTR:  EPS:       -.27/share     REV:  2.21/M
     FULL YR:     EPS:        .91/share     REV: 11,160/M

*These are the base metrics we will be watching against the actual release numbers


PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -9.52, 13.4, -13.37



*** With market volatility at extremes during the coronavirus pandemic there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before trading. 

Links To Latest News and Headlines

19 Oct, 2020 @ 16:28 by Yahoo! Finance

Markets in the red, shares of Halliburton jumps on quarterly results

17 Oct, 2020 @ 01:43 by Yahoo! Finance

The list of retailers saying they will close this Thanksgiving is piling up.

In its latest business update, L Brands reported sales growth at Bath & Body Works and announced a 15% headcount reduction at the corporate headquarters.

30 Jul, 2020 @ 14:47 by Yahoo! Finance

JPMorgan analyst Matthew Boss raised L Brands' (LB) stock rating to Buy from Hold on Wednesday, after the company provided a separation update related to Victoria’s Secret and Bath & Body Works. Boss also lifted his price target to $32 (23.6% upside potential) from $14.Shares are down 2.4% in Thursday's pre-market trading after jumping 35.4% to $6.76 on Wednesday.On July 28, L Brands divided Victoria’s Secret and Bath & Body Works into two independent companies. In addition, L Brands said it expects Bath & Body Works 2Q sales to rise by a preliminary 10% and Victoria’s Secret sales to fall by 40%.Boss believes that the Bath & Body Works division represents the “best current [comparison] story” in brick-and-mortar retail. He further added in a commentary cited by Bloomberg that Bath & Body Works would likely have “a sustainable double-digit stand-alone bottom-line growth profile.”On July 29, KeyBanc analyst Edward Yruma raised his price target to $28 (8.2% upside potential) from $25, saying that “Bath & Body Works remains one of the best stories in consumer/ retail”. He added that “unlike at the beginning of the pandemic (when soaps and sanitizers outperformed), Bath & Body Works’ strong sales results are being driven across its product suite.”Currently, the Street has a cautiously optimistic outlook on the stock. The Moderate Buy analyst consensus is based on 8 Buys, 7 Holds, and 2 Sells. The average price target of $22.13 implies downside potential of 14.5%. (See LB stock analysis on TipRanks).Related News: FireEye Pops 18% As JPMorgan Lifts PT McDonald’s PT Gets A Lift From JPMorgan Morgan Stanley Lifts Price Target On Tesla Stock More recent articles from Smarter Analyst: * Exxon Is Said To Prepare Spending, Job Cuts To Save Dividend; Shares Drop * Citigroup Turns Bullish On American Eagle * BMO Capital Lifts Amazon's PT Ahead OF 2Q Earnings * Procter & Gamble Tops 4Q Street Estimates

StockJumpers analysis and trade plans are uploaded generally 1 HOUR BEFORE MARKETS CLOSE (3PM EST) for most events.

“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up  Looking forward to having you on-board ASAP”

There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory. 

NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.